Do Institutional Investors Love Sabra Health Care REIT Inc (NASDAQ:SBRA)?

Paterniano Del Favero
Luglio 18, 2017

The hedge fund held 351,170 shares of the consumer services company at the end of 2016Q4, valued at $8.58 million, down from 379,615 at the end of the previous reported quarter. Ns Advisors Llc who had been investing in Sabra Health Care Reit Inc for a number of months, seems to be less bullish one the $1.53B market cap company. The stock increased 1.19% or $2.09 on July 14, reaching $177.13.

Sabra Health Care REIT Inc (NASDAQ:SBRA) institutional sentiment increased to 1.31 in Q4 2016.

Want to see what other hedge funds are holding SBRA? (NASDAQ:AMGN) to report earnings on July, 25 after the close. The stock increased 0.42% or $0.21 during the last trading session, reaching $50.56. About shares traded. Amgen, Inc. Oracle Corporation (NYSE:ORCL) has risen 14.08% since July 17, 2016 and is uptrending. It has underperformed by 11.43% the S&P500. Its down 0.17, from 1.26 in 2016Q3.

Investors sentiment increased to 0.88 in 2016 Q4. 29 funds opened positions while 72 raised stakes. Axa reported 10,000 shares stake. Art Advisors Limited Liability Com holds 0.04% in Sabra Health Care REIT Inc (NASDAQ:SBRA) or 30,100 shares. The stock of Sabra Health Care REIT Inc (NASDAQ:SBRA) earned "Outperform" rating by FBR Capital on Tuesday, February 23. Moreover, Susquehanna Intl Ltd Liability Partnership has 0% invested in Sabra Health Care REIT Inc (NASDAQ:SBRA). (NASDAQ:AMGN). First Natl Natl Bank Communications Of Newtown invested 0.13% in Amgen, Inc. It dropped, as 98 investors sold AMGN shares while 488 reduced holdings. Trustmark Bank & Trust Trust Department invested in 7,006 shares or 0.14% of the stock. D E Shaw & stated it has 0% of its portfolio in Sabra Health Care REIT Inc (NASDAQ:SBRA). Washington Tru State Bank owns 6,114 shares for 0.2% of their portfolio. (NASDAQ:AMGN). Engineers Gate Manager Lp has invested 0.03% in Amgen, Inc. Zacks Investment Research raised shares of Sabra Healthcare REIT from a "sell" rating to a "hold" rating in a research report on Tuesday, July 11th. Therefore 29% are positive. Sabra Health Care REIT has $32 highest and $21 lowest target. The company presently has a consensus rating of "Hold" and a consensus price target of $26.57. SBRA was included in 29 notes of analysts from July 21, 2015. The rating was upgraded by Mizuho on Thursday, August 6 to "Buy". Mizuho downgraded the stock to "Underperform" rating in Monday, July 10 report. The ratio improved, as 101 investment managers increased or opened new stock positions, while 77 cut down and sold their stakes in Sabra Health Care REIT Inc. The rating was maintained by UBS on Thursday, October 29 with "Buy". On Thursday, May 19 the stock rating was downgraded by Mizuho to "Neutral". The firm has "Neutral" rating by SunTrust given on Wednesday, November 11. The firm has "Outperform" rating given on Tuesday, November 10 by FBR Capital. Also, the number of investment managers holding Sabra Health Care REIT Inc in their top 10 holdings was flat from 3 to 3 for the same number. "Participating in the JMP Securities Boston Real ..." on July 06, 2017, also published article titled: "Sabra Health Care REIT, Participate in the Wells Fargo 20th Annual ...", published: "Sabra Health Care REIT, Care Capital Properties Merge" on May 09, 2017.

Sabra Healthcare REIT (NASDAQ:SBRA) last issued its earnings results on Monday, May 8th. Equities analysts anticipate that Sabra Healthcare REIT, Inc. will post $1.20 EPS for the current fiscal year. During the same period in the previous year, the business earned $0.54 earnings per share. Zurcher Kantonalbank Zurich Cantonalbank now owns 3,799 shares of the real estate investment trust's stock worth $106,000 after buying an additional 471 shares in the last quarter. (NYSE:XOM) by 4,197 shares in the quarter, leaving it with 117,364 shares, and cut its stake in Caterpillar (NYSE:CAT). "(NASDAQ:SBRA) Upgraded at Zacks Investment Research" was originally posted by Chaffey Breeze and is the property of of Chaffey Breeze. The ex-dividend date was Tuesday the 16th of May 2017. Three investment analysts have rated the stock with a sell rating, seven have assigned a hold rating and two have given a buy rating to the stock. Therefore 71% are positive. Pacific Crest maintained the stock with "Sector Weight" rating in Friday, June 17 report. Drexel Hamilton maintained it with "Buy" rating and $5300 target in Wednesday, June 21 report. BMO Capital Markets initiated it with "Market Perform" rating and $42.0 target in Friday, January 8 report.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Altre relazioni OverNewsmagazine

Discuti questo articolo